Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches
Recruiting now
Conditions studied: Hepatocarcinoma
In brief
This is a national, observational, retrospective, cross-sectional, non-profit study focused on patients with HCC. The study aims to characterize the expression and function of novel noncoding regulatory transcripts, including those containing TEsin the microenvironment of liver tumors, with emphasis on their role in T cell dysfunction.
Key facts
- Study ID
- NCT07432347
- Run by
- Niguarda Hospital
- People needed
- 270
- Starts
- 2026-01-01
- Expected to finish
- 2031-01-31
- Last updated by the study team
- 2026-02-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- ASST GOM Niguarda — Milan, Lombardy, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.